Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Blood Cancer Journal
|
April 9, 2016
Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations
D Barraco, Y C Elala, T L Lasho, et al.
Blood Cancer Journal
|
May 7, 2016
Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations
D Barraco, Y C Elala, T L Lasho, et al.
Leukemia
|
May 6, 2014
Calreticulin mutations and long-term survival in essential thrombocythemia
A Tefferi, E A Wassie, T L Lasho, et al.
Leukemia
|
March 6, 2013
Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis
A Pardanani, R R Laborde, T L Lasho, et al.
Leukemia
|
February 3, 2015
Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells
A Pardanani, T Lasho, D Chen, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
November 13, 2020
E.U. paediatric MOG consortium consensus: Part 4 - Outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
Arlette L Bruijstens, Markus Breu, Eva-Maria Wendel, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
November 9, 2020
E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
Arlette L Bruijstens, Christian Lechner, Lorraine Flet-Berliac, et al.
Leukemia
|
June 2, 2007
TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations
A Pardanani, J Hood, T Lasho, et al.
Leukemia
|
October 18, 2014
Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis
A Pardanani, R A Abdelrahman, C Finke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 14, 2014
Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue
C Finke, J Schlichting, S Papazoglou, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Blood Cancer Journal
|
April 9, 2016
Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations
D Barraco, Y C Elala, T L Lasho, et al.
Blood Cancer Journal
|
May 7, 2016
Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations
D Barraco, Y C Elala, T L Lasho, et al.
Leukemia
|
May 6, 2014
Calreticulin mutations and long-term survival in essential thrombocythemia
A Tefferi, E A Wassie, T L Lasho, et al.
Leukemia
|
March 6, 2013
Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis
A Pardanani, R R Laborde, T L Lasho, et al.
Leukemia
|
February 3, 2015
Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells
A Pardanani, T Lasho, D Chen, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
November 13, 2020
E.U. paediatric MOG consortium consensus: Part 4 - Outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
Arlette L Bruijstens, Markus Breu, Eva-Maria Wendel, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
November 9, 2020
E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
Arlette L Bruijstens, Christian Lechner, Lorraine Flet-Berliac, et al.
Leukemia
|
June 2, 2007
TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations
A Pardanani, J Hood, T Lasho, et al.
Leukemia
|
October 18, 2014
Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis
A Pardanani, R A Abdelrahman, C Finke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 14, 2014
Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue
C Finke, J Schlichting, S Papazoglou, et al.
Page
of 7